Seoul, South Korea

Samyang Genex Corporation


USPTO Granted Patents = 18

% Expired Patents = 11.1

Trademarks = 1

Forward Citations = 61

Loading Chart...
Loading Chart...

60 inventors (with patents filed for the assignee):

goldMedal Hyun-soo Lee (6 out of 16 patents)

silverMedal Ho-Joon Choi (6 out of 10 patents)

bronzeMedal Seung-Suh Hong (6 out of 13 patents)

4.  Hoon Ryu (5 out of 31 patents)

5.  Young Jae Jung (5 out of 9 patents)

6.  Do Hyun Kyung (4 out of 7 patents)

7.  Bong-Kyu Song (4 out of 6 patents)

8.  Jin Kyung Kim (4 out of 23 patents)

9.  Hyuk Min Park (3 out of 7 patents)

10.  Sang-Hyun Pyo (3 out of 5 patents)

11.  Jin-Suk Cho (3 out of 5 patents)

12.  Moon-Suk Kim (3 out of 6 patents)

13.  Seong Ho Cho (3 out of 52 patents)

14.  Jeong-Hwan Yun (2 out of 5 patents)

15.  Chong Jin Park (2 out of 2 patents)


18 patents:

Company Overview
Samyang Genex Corporation, based in Seoul, South Korea, specializes in the development and manufacturing of advanced biopharmaceuticals and innovative healthcare solutions. The company focuses on research in areas such as drug delivery systems, regenerative medicine, and therapeutic agents, aiming to enhance patient outcomes through cutting-edge technology. With a commitment to scientific excellence, Samyang Genex plays a significant role in the global biopharmaceutical landscape, contributing to advancements in medical treatments and therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

18 Patents

#254 in Seoul

#688 in South Korea

#34,217 in the World

Seoul, KR
Seoul, South Korea
Forward Citations = 61

60 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Samyang Genex Corporation. Retrieved from https://idiyas.com/company/samyang-genex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…